Understanding the mode of action of the primaquine: New insights into a 70 year old puzzle

Understanding the mode of action of the primaquine: New insights into a 70 year old puzzle
Credit: LSTM

Researchers at LSTM have taken significant steps in understanding the way that the anti-malarial drug primaquine (PQ) works, which they hope will lead to the development of new, safer and more effective treatments for malaria.

The , which was predominantly funded following an award from the Medical Research Council, has been carried out by the LSTM's Centre for Drugs and Diagnostic (CDD). The results are published in the journal Nature Communications.

LSTM's Professor Giancarlo Biagini explained: "The antimalarial is a cornerstone of global efforts to eliminate malaria, for some 70 years it has been the only drug registered that has been demonstrated to be able to cure relapsing malaria and block transmission of the disease. However, little has previously been understood about the drug's mode of action, which is seriously undermining efforts to improve the safety and pharmacology profile of this important drug class."

The team at LSTM, working with key collaborators including Professor Paul O'Neill (University of Liverpool), Professor David Baker (London School of Hygiene and Tropical Medicine) and Professor Sangeeta Bhatia (Massachusetts Institute of Technology, USA) were able to replicate the interaction between the drug and the host enzymes which catalyse the generation of cytotoxic amounts of hydrogen peroxide from metabolites of PQ. The experiments were able to demonstrate why the drug displays exquisite selectivity against specific parasite stages and also explains why only very small (nM) catalytic concentrations of metabolites are necessary to kill the parasites.

The search for new antimalarials is vital in the drive towards global malaria elimination, especially given that PQ is potentially lethal to people with the genetic disorder glucose-6-phoshate dehydrogenase (G6PD) deficiency, which affects millions of people in malaria-endemic countries.

"This is why an understanding of how the works is central to replicating its most significant elements." Continued Professor Biagini: "This work has been possible with CDD given the multidisciplinary nature of the team. The current study makes a significant advancement in our understanding of PQ mechanism of action. This is key to the development of newer and safer, broad-spectrum , work currently underway within our group."

Explore further

Low-dose treatment may block malaria transmission

More information: Grazia Camarda et al, Antimalarial activity of primaquine operates via a two-step biochemical relay, Nature Communications (2019). DOI: 10.1038/s41467-019-11239-0
Journal information: Nature Communications

Citation: Understanding the mode of action of the primaquine: New insights into a 70 year old puzzle (2019, July 19) retrieved 22 August 2019 from https://medicalxpress.com/news/2019-07-mode-action-primaquine-insights-year.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more